Drugs / POTASSIUM PHOSPHATE, UNSPECIFIED FORM
POTASSIUM PHOSPHATE, UNSPECIFIED FORM
also known as
potassium phosphate · Kali phosphoricum · Kalium phosphoricum · Potassium (as phosphate)
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | AMINOSYN 10% (PH6) | — | 1975-12-03 | fda.gov ↗ |
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT07681050 | Jul 2026 → Jul 2028 expected | acute pancreatitis | Duke University | Recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00004284 | Apr 1995 → ? | idiopathic hypercalciuria, nephrolithiasis | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04026438 | Jan 2019 → Feb 2021 | post-surgical hypoinsulinemia | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT02866435 Background | Nov 2016 → Sep 2019 | hypoglycemia | University of Minnesota | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | POTASSIUM PHOSPHATE, UNSPECIFIED FORM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298074 ↗ |
| Known as | Kali phosphoricum | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298074 ↗ |
| Known as | Kalium phosphoricum | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298074 ↗ |
| Known as | Potassium (as phosphate) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298074 ↗ |
| Known as | potassium phosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004284 ↗ |
| Route | Oral | “Patients receive potassium phosphate or potassium citrate tablets twice a day for 3 years.” NCT00004284 ↗ |